Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pediatr Infect Dis J ; 32(5): 460-6, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23348811

RESUMO

BACKGROUND: The clinical impact of polymicrobial respiratory infections remains uncertain. Previous reports are contradictory regarding an association with severe disease. METHODS: Three hundred forty-six specimens from children with acute respiratory illness identified at the University of Iowa Hospitals and Clinics Clinical Microbiology Laboratory were evaluated by direct immunofluorescent assay and/or viral culture by Clinical Microbiology Laboratory and later by molecular study for the presence of influenza, parainfluenza, respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus and human bocavirus. Demographic and clinical data were abstracted from medical records. RESULTS: Multiple viruses were detected in 46 (21.7%) of 212 virus-positive specimens with the most frequent virus-virus combinations being HRV-respiratory syncytial virus (n = 12), HRV-human bocavirus (n = 6) and HRV-parainfluenza virus 3 (n = 4). Risk factors for coinfection included male gender (OR [odds ratio]: 1.70, 95% confidence interval [CI]: 0.83-3.46), 6 months to 1 year age (OR: 2.15, 95% CI: 0.75-6.19) and history of immunosuppression (OR: 2.05, 95% CI: 0.99-4.23). Children with viral coinfections were less likely than children with single virus infections to be admitted to an intensive care unit (OR: 0.32, 95% CI: 0.08-1.27); however, this may be explained by undetected viral-bacterial coinfections. CONCLUSIONS: HRV, respiratory syncytial virus, human bocavirus, and polymicrobial infections were prevalent in this study. Although the cross-sectional design could not easily examine polymicrobial infection and disease severity, prospective, population-based research regarding the clinical impact of such infections is warranted.


Assuntos
Coinfecção/microbiologia , Infecções Respiratórias/microbiologia , Viroses/microbiologia , Doença Aguda , Infecções Bacterianas/microbiologia , Infecções Bacterianas/virologia , Criança , Pré-Escolar , Coinfecção/virologia , Estudos Transversais , Feminino , Hospitais Pediátricos , Humanos , Lactente , Masculino , Infecções Respiratórias/virologia , Estudos Retrospectivos , Fatores de Risco , Viroses/virologia
2.
J Clin Virol ; 46(4): 331-6, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19854101

RESUMO

BACKGROUND: Adenovirus type 3 (HAdV3) is one of the most prevalent serotypes detected globally. Variants of HAdV3 have been associated with outbreaks of severe disease. OBJECTIVES: To better understand genetic diversity of circulating HAdV3s and examine risk factors for severe disease. STUDY DESIGN: Restriction enzyme analysis for genomic characterization of clinical HAdV3 isolates detected by 15 collaborative US laboratories during the period July 2004 to May 2007. Multivariate modeling was employed for statistical analyses. RESULTS: The most common HAdV3 types of 516 isolates studied were HAdV3a2 (36.9%), HAdV3a50 (27.1%), HAdV3a51 (18.0%), and HAdV3a17 (4.6%). Non-HAdV3a genome types were rare (1.2%). HAdV3a50 and HAdV3a51 are newly described variants which became more prevalent in 2006 and 2007 and have been associated with at least one epidemic. Their uniqueness was determined by specific banding profiles generated by digests with endonucleases BclI, BglII, and HindIII. Multivariable risk factor modeling demonstrated that children under 2 years of age (OR=2.7; 95%CI 1.6-4.6), persons with chronic disease (OR=5.1; 95%CI 2.6-9.8), persons infected with HAdV3a2 (OR=3.0; 95%CI 1.5-6.0), with HAdV3a50 (OR=2.5; 95%CI 1.2-5.2), or with multiple or rare strains (OR=2.8; 95%CI 1.3-6.5) were at increased risk of severe HAdV3 clinical disease. CONCLUSIONS: In the study period considerable genetic diversity was found among US clinical HAdV3 strains. Novel variants emerged and became prevalent. One such emergent strain may be associated with more severe clinical disease.


Assuntos
Infecções por Adenovirus Humanos/epidemiologia , Infecções por Adenovirus Humanos/virologia , Adenovírus Humanos/genética , Adenovírus Humanos/fisiologia , Criança , Pré-Escolar , Feminino , Genoma Viral/genética , Genoma Viral/fisiologia , Humanos , Lactente , Recém-Nascido , Masculino , Análise Multivariada , Fatores de Risco , Estados Unidos/epidemiologia
3.
Pediatr Res ; 62(1): 26-31, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17515840

RESUMO

11-Beta hydroxysteroid dehydrogenase type 2 (HSD2) oxidizes the biologically active glucocorticoid (GC), cortisol, to inactive cortisone. We characterized HSD2 gene expression and activity in human adult and fetal lung tissues and in cultured fetal lung explants, and examined the potential regulation of HSD2 in the fetal lung by sex steroids. Human adult lung, fetal lung, and cultured fetal lung explant tissues contained similar amounts of HSD2 mRNA. However, higher levels of HSD2 protein were detected in human fetal lung tissue than in adult lung, with expression being restricted to a subset of epithelial cells in the fetal lung tissue. Differentiated fetal lung explants maintained in culture expressed higher levels of HSD2 protein and enzymatic activity than undifferentiated fetal lung tissues. Finally, HSD2 protein levels were decreased in male, but not female, fetal lung explants treated with 17-beta estradiol. In contrast, 5-alpha dihydrotestosterone did not significantly affect HSD2 levels. These data indicate that HSD2 protein and activity levels increase in parallel with the differentiation of alveolar type II epithelial cells in vitro, and that HSD2 protein levels are regulated by 17-beta estradiol in male fetal lung tissue.


Assuntos
11-beta-Hidroxiesteroide Desidrogenase Tipo 2/metabolismo , Feto/enzimologia , Pulmão/enzimologia , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/genética , Adulto , Androgênios/metabolismo , Di-Hidrotestosterona/metabolismo , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Estradiol/metabolismo , Feminino , Feto/anatomia & histologia , Regulação da Expressão Gênica no Desenvolvimento , Regulação Enzimológica da Expressão Gênica , Humanos , Pulmão/anatomia & histologia , Pulmão/embriologia , Masculino , Gravidez
4.
Am J Physiol Lung Cell Mol Physiol ; 282(3): L386-93, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11839531

RESUMO

Surfactant protein A (SP-A) is the most abundant of the surfactant-associated proteins. SP-A is involved in the formation of tubular myelin, the modulation of the surface tension-reducing properties of surfactant phospholipids, the metabolism of surfactant phospholipids, and local pulmonary host defense. We hypothesized that elimination of SP-A would alter the regulation of SP-B gene expression and the formation of tubular myelin. Midtrimester human fetal lung explants were cultured for 3-5 days in the presence or absence of an antisense 18-mer phosphorothioate oligonucleotide (ON) complementary to SP-A mRNA. After 3 days in culture, SP-A mRNA was undetectable in antisense ON-treated explants. After 5 days in culture, levels of SP-A protein were also decreased by antisense treatment. SP-B mRNA levels were not affected by the antisense SP-A ON treatment. However, there was decreased tubular myelin formation in the antisense SP-A ON-treated tissue. We conclude that selective elimination of SP-A mRNA and protein results in a decrease in tubular myelin formation in human fetal lung without affecting SP-B mRNA. We speculate that SP-A is critical to the formation of tubular myelin during human lung development and that the regulation of SP-B gene expression is independent of SP-A gene expression.


Assuntos
Pulmão/embriologia , Bainha de Mielina/metabolismo , Oligonucleotídeos Antissenso/farmacologia , Proteolipídeos/antagonistas & inibidores , Surfactantes Pulmonares/antagonistas & inibidores , Resinas de Troca de Cátion/farmacologia , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Feto/metabolismo , Homeostase , Humanos , Imuno-Histoquímica , Técnicas In Vitro , L-Lactato Desidrogenase/metabolismo , Lipídeos/farmacologia , Proteolipídeos/genética , Proteolipídeos/metabolismo , Proteína A Associada a Surfactante Pulmonar , Proteínas Associadas a Surfactantes Pulmonares , Surfactantes Pulmonares/genética , Surfactantes Pulmonares/metabolismo , RNA Mensageiro/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA